Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|October 6, 2025
Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care settingHolly Wobma, Lauren A Henderson, Christine N Duncan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemiaRachel Kobos, Peter G Steinherz, Nancy A Kernan, et al.
British Journal of Haematology|February 28, 2008
Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemiaSonali Chaudhury, Arleen D Auerbach, Nancy A Kernan, et al.
Blood|January 17, 2014
Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigationFarid Boulad, Xiuyan Wang, Jinrong Qu, et al.
Pediatric Blood & Cancer|December 8, 2011
Paroxysmal nocturnal hemoglobinuria in pediatric patientsKevin J Curran, Nancy A Kernan, Susan E Prockop, et al.
Pediatric Blood & Cancer|September 17, 2013
Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantationLisa Giulino-Roth, Rosanna Ricafort, Nancy A Kernan, et al.
Cytotherapy|June 18, 2023
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisAlexandre G Troullioud Lucas, Caroline A Lindemans, Senthil Velan Bhoopalan, et al.
The Journal of Infectious Diseases|May 7, 2020
Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single CenterYeon Joo Lee, Jiaqi Fang, Phaedon D Zavras, et al.
Cytotherapy|September 25, 2024
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committeeJoseph H Oved, Athena Russell, Amy DeZern, et al.
Transplantation and Cellular Therapy|October 9, 2022
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell TransplantationEllen Fraint, Sana Farooki, Elizabeth Klein, et al.
Pageof 7